January 13, 2025 - 04:31

Since the election, China has flexed its military might in both overt and covert ways, highlighting significant challenges for the United States and its allies. The Chinese government has ramped up military exercises in the South China Sea, asserting its claims over disputed territories and demonstrating its naval capabilities. These maneuvers have raised alarms among neighboring countries and the international community, who view them as aggressive posturing.
Additionally, reports indicate that China is enhancing its cyber warfare capabilities, potentially targeting critical infrastructure in the U.S. and allied nations. This dual approach of military readiness and cyber aggression signals a strategic shift aimed at countering perceived threats from the West.
As tensions rise, the prospect of a return to the White House by Donald Trump adds another layer of complexity to U.S.-China relations. The former president's unpredictable foreign policy style could lead to further escalations, making it crucial for U.S. leaders to navigate this evolving landscape with caution.
January 25, 2026 - 20:36
Minnesota’s Biggest Companies Call for ‘De-escalation’ of TensionsChief executives from several of Minnesota`s largest and most prominent companies, including retail giant Target and agricultural conglomerate Cargill, have jointly issued a public letter calling...
January 25, 2026 - 12:28
Bob on Business: Fort Worth Stock Show with a high-end ‘Landman’ twistThe iconic Fort Worth Stock Show & Rodeo, a century-old celebration of Western heritage, is witnessing a notable shift in its patronage, reflecting the region`s booming energy sector. Observers...
January 24, 2026 - 23:38
How seat-back psychology helped a WA business build a safety card dynastyNestled in Lacey, Washington, a quiet manufacturing success story has been unfolding for decades, one airplane seat-back pocket at a time. A local company has become an unlikely dynasty, producing...
January 24, 2026 - 02:33
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trialsThe pharmaceutical company Moderna is scaling back its plans to invest in new late-stage clinical trials for infectious disease vaccines, citing a challenging environment. A significant factor in...